Form 4: Castellum Director Granted 100,000 Stock Options
Insider Transaction Report
Castellum, Inc. director John Francis Campbell received 100,000 stock options as compensation, exercisable at $1.19 per share.
Summary
- John Francis Campbell, a Director of Castellum, Inc. (CTM), was granted 100,000 stock options.
- The options were granted on November 11, 2025, as compensation for his service as an independent member of the Board of Directors.
- The exercise price for these options is $1.19 per share.
- These options will vest ratably over a period of twenty months, commencing on December 1, 2025.
- The expiration date for these stock options is November 10, 2032.
- The grant was made pursuant to the terms of the Castellum, Inc. Second Amended 2021 Stock Incentive Plan.
Sentiment
Score: 6
Explanation: The filing reports a routine compensation event for a director, which is generally a neutral to slightly positive signal as it aligns interests, but does not indicate significant operational or financial performance changes.
Positives
- The grant of stock options aligns the director's interests with those of shareholders, incentivizing long-term company performance.
- Compensation through equity instruments is a common practice for independent directors, reflecting standard corporate governance.
Risks
- Potential future dilution for existing shareholders if the options are exercised and new shares are issued.
Future Outlook
The stock options will vest ratably over a twenty-month period starting December 1, 2025, providing a future incentive for the director's continued service and performance.
Industry Context
The grant of stock options to an independent director is a standard practice in the U.S. public company landscape, aligning director incentives with shareholder value creation and is a common component of executive and director compensation packages across various industries.
Comparison to Industry Standards
- Director compensation packages often include a mix of cash and equity, with stock options or restricted stock units being prevalent. This grant is consistent with typical equity compensation structures for independent directors in publicly traded companies.
- The vesting schedule over 20 months is a common mechanism to ensure continued service and long-term commitment, comparable to practices seen at companies like Lockheed Martin or Northrop Grumman for their board members, though the specific number of options and exercise price would vary based on company size and stock price.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy | The stock option grant was made pursuant to the Castellum, Inc. Second Amended 2021 Stock Incentive Plan, indicating the company's established framework for equity-based compensation. | 11/11/2025 | Reinforces the company's existing compensation structure for directors, aligning their interests with long-term shareholder value. |
Related Party Transactions
- The grant of 100,000 stock options to John Francis Campbell, an independent director, constitutes a related party transaction as it involves compensation to a member of the company's board.
Stakeholder Impact
- Shareholders: Potential for minor dilution if options are exercised, but also benefit from increased director alignment with long-term company performance.
- Director (John Francis Campbell): Receives equity-based compensation, providing a direct financial incentive tied to the company's stock performance.
Next Steps
- The stock options will begin vesting on December 1, 2025, and continue ratably over the subsequent twenty months.
Key Dates
| Date | Description |
|---|---|
| 11/11/2025 | Date of earliest transaction (stock option grant). |
| 12/01/2025 | Commencement date for the ratable vesting of stock options over twenty months. |
| 11/10/2032 | Expiration date of the granted stock options. |
| 11/13/2025 | Signature date of the reporting person on the Form 4 filing. |
Keywords
Castellum Inc, CTM, stock options, director compensation, insider transaction, SEC Form 4, equity incentive plan, corporate governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.